Kinetics of intravenous pyridostigmine in man.
作者信息
Calvey T N, Chan K, Dehghan A, Williams N E
出版信息
Br J Clin Pharmacol. 1981 Apr;11(4):406-8. doi: 10.1111/j.1365-2125.1981.tb01146.x.
Abstract
摘要
相似文献
1
Kinetics of intravenous pyridostigmine in man.
Br J Clin Pharmacol. 1981 Apr;11(4):406-8. doi: 10.1111/j.1365-2125.1981.tb01146.x.
2
Pyridostigmine kinetics with and without renal function.
Clin Pharmacol Ther. 1980 Jul;28(1):78-81. doi: 10.1038/clpt.1980.134.
3
Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis.
Clin Pharmacol Ther. 1985 May;37(5):495-501. doi: 10.1038/clpt.1985.78.
4
The pharmacokinetics of pyridostigmine and 3-hydroxy-N-methylpyridinium in the rat: dose-dependent effects after portal vein administration.
Br J Pharmacol. 1975 Nov;55(3):335-41. doi: 10.1111/j.1476-5381.1975.tb06936.x.
5
Renal clearance of pyridostigmine in patients with myasthenia gravis.
Eur Neurol. 1977;16(1-6):69-72. doi: 10.1159/000114882.
6
The effect of neostigmine on pyridostigmine bioavailability in myasthenic patients after oral administration.
Methods Find Exp Clin Pharmacol. 1981 Sep-Oct;3(5):291-6.
7
Pyridostigmine metabolism in man.
Clin Pharmacol Ther. 1972 May-Jun;13(3):393-9. doi: 10.1002/cpt1972133393.
8
Studies on the absorption of pyridostigmine: the application of a spectrophotometric method for the determination of pyridostigmine in plasma.
Z Klin Chem Klin Biochem. 1974 Jun;12(6):273-5. doi: 10.1515/cclm.1974.12.6.273.
9
In vitro metabolism of neostigmine and pyridostigmine.
J Pharm Pharmacol. 1973 May;25(5):428-9. doi: 10.1111/j.2042-7158.1973.tb10045.x.
10
In vitro synthesis of metabolites of 14C-pyridostigmine.
Experientia. 1974 May 15;30(5):527. doi: 10.1007/BF01926331.
引用本文的文献
1
Assessment of neuromuscular blockade by electromyography: a review.
J R Soc Med. 1984 Jan;77(1):56-9. doi: 10.1177/014107688407700114.
2
Clinical pharmacokinetics of cholinesterase inhibitors.
Clin Pharmacokinet. 1986 May-Jun;11(3):236-49. doi: 10.2165/00003088-198611030-00005.
本文引用的文献
1
Pyridostigmin (mestinon) as an antagonist of d-tubocurarine.
Anesthesiology. 1967 May-Jun;28(3):528-34.
2
Comparative times to peak effect and durations of action of neostigmine and pyridostigmine.
Anesthesiology. 1974 Jul;41(1):27-33. doi: 10.1097/00000542-197407000-00005.
3
Pyridostigmine metabolism in man.
Clin Pharmacol Ther. 1972 May-Jun;13(3):393-9. doi: 10.1002/cpt1972133393.
4
A quantitative gas-liquid chromatographic method for the determination of neostigmine and pyridostigmine in human plasma.
J Chromatogr. 1976 May 26;120(2):349-58. doi: 10.1016/s0021-9673(76)80012-x.
5
Plasma clearance of neostigmine and pyridostigmine in the dog.
Br J Pharmacol. 1978 Jul;63(3):509-12. doi: 10.1111/j.1476-5381.1978.tb07805.x.
6
Pharmacokinetics and pharmacological effects of neostigmine in man.
Br J Clin Pharmacol. 1979 Feb;7(2):149-55. doi: 10.1111/j.1365-2125.1979.tb00915.x.
Zotero 插件